Hoi-Yoon Jung
Chief Executive Officer bei NOVMETAPHARMA CO., LTD.
Profil
Hoi-Yoon Jung is currently the Co-CEO, Director & Head-Research at NovMetaPharma Co., Ltd.
and the Research & Development Director at NovMetaHealth Co. Ltd.
Additionally, he is a Professor at Pohang University of Science & Technology since 2019.
He holds a doctorate degree from Pohang University of Science & Technology and undergraduate and graduate degrees from Handong Global University.
Aktive Positionen von Hoi-Yoon Jung
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVMETAPHARMA CO., LTD. | Chief Executive Officer | - |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The private company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Chief Tech/Sci/R&D Officer | - |
| Pohang University of Science & Technology | Corporate Officer/Principal | 01.01.2019 |
Ausbildung von Hoi-Yoon Jung
| Pohang University of Science & Technology | Doctorate Degree |
| Handong Global University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVMETAPHARMA CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The private company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
